Stockreport

Novo launches $249 Wegovy subscription, undercutting Lilly as shares fall 30% [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Novo Nordisk ( NYSE:NVO ) is stepping up its push to regain share in the obesity drug market, introducing a subscription-based pricing model that could improve access a [Read more]